Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile

References

• Juonala M, Kähönen M, Laitinen T, et al. Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: the cardiovascular risk in Young Finns Study. Eur Heart J 2008;29:1198–206
   PubMed Web of Science ®Google Scholar
• Meyer C, McGrath BP, Teede HJ. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab 2005;90:5711–6
   PubMed Web of Science ®Google Scholar
• Dahlgren E, Johansson S, Lindstedt G, et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history on circulating hormones. Fertil Steril 1992;57:505–13
   PubMed Web of Science ®Google Scholar
• Mather KJ, Verma S, Corenblum B, Anderson TJ. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2000;85:1851–6
   PubMed Web of Science ®Google Scholar
• Brinkworth GD, Noakes M, Moran LJ, et al. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome. BJOG 2006;113:1308–14
   PubMed Web of Science ®Google Scholar
• Talbott EO, Guzick DS, Sutton-Tyrrell K, et al. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 2000;20:2414–21
   PubMed Web of Science ®Google Scholar
• Vryonidou A, Papatheodorou A, Tavridou A, et al. Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:2740–6
   PubMed Web of Science ®Google Scholar
• OrioJr F, Palomba S, Cascella T, et al. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004;89:4588–93
   PubMed Web of Science ®Google Scholar
• Sorensen MB, Franks S, Robertson C, et al. Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors. Clin Endocrinol (Oxf) 2006;65:655–9
   PubMed Web of Science ®Google Scholar
• Paradisi G, Steinberg HO, Hempfling A, et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001;103:1410–5
   PubMed Web of Science ®Google Scholar
• Kapiotis S, Holzer G, Schaller G, et al. A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol 2006;26:2541–6
   PubMed Web of Science ®Google Scholar
• Prior JO, Quiñones MJ, Hernandez-Pampaloni M, et al. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 2005;111:2291–8
   PubMedGoogle Scholar
• Genuth S, Alberti KG, Bennett P, et al. The expert committee on the diagnosis and classification of diabetes mellitus: follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160–7
   PubMed Web of Science ®Google Scholar
• World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part I. Diagnosis and classification of diabetes mellitus. Geneva: WHO; 1999
   Google Scholar
• Rotterdam ESHRE/ASRM – Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
   Web of Science ®Google Scholar
• Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440–7
   PubMed Web of Science ®Google Scholar
• Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421
   Google Scholar
• Rocha MP, Maranhão RC, Seydell TM, et al. Metabolism of trygliceride-rich lipoproteins and lipid transfer to high-density lipoprotein in young obese and normal-weight patients with polycystic ovary syndrome. Fertil Steril 2010;93:1948–56
   PubMedGoogle Scholar
• Vermeulen A, Verdonck L and Kaufman JM. A critical evaluation of simple methods for estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666–72
   PubMed Web of Science ®Google Scholar
• Lage SG, Kopel L, Medeiros CCJ, et al. Angiotensin II contributes to arterial compliance in congestive heart failure. Am J Physiol Heart Circ Physiol 2002;283:H3–6
   Google Scholar
• De Lima JJ, Vieira ML, Vviviani LF, et al. Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients. Nephrol Dial Transplant 2002;17:645–51
   PubMedGoogle Scholar
• Coimbra SR, Lage SH, Brandizzi L, et al. The action of red wine and purple grape juice on vascular reactivity is independent of plasma lipids in hypercholesterolemic patients. Braz J Med Biol Res 2005;38:1339–47
   PubMed Web of Science ®Google Scholar
• Oflaz H, Ozbey N, Mantar F, et al. Determination of endothelial function and early atherosclerotic changes in healthy obese women. Diabetes Nutr Metab 2003;16:176–81
   PubMedGoogle Scholar
• De Michele M, Panico S, Ianuzzi A, et al. Association of obesity and central fat distribution with carotid artery wall thickenning in middle-age women. Stroke 2002;33:2923–8
   PubMed Web of Science ®Google Scholar
• Robinson MR, Scheuermann-Freestone M, Leeson P, et al. Uncomplicated obesity is associated with abnormal aortic function assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008;13:10–7
   Google Scholar
• Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 1992: 377–84
   Google Scholar
• Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:4237–45
   PubMed Web of Science ®Google Scholar
• Bartoli E, Fra GP, Carnevale-Schianca CA. The oral glucose tolerance test (OGTT) revisited. Eur J Intern Med 2011;22:8–12
   PubMed Web of Science ®Google Scholar
• Barcellos CR, Rocha MP, Hayashida SA, et al. Prevalence of abnormalities of glucose metabolism in patients with polycystic ovary syndrome. Arq Bras Endocrinol Metabol 2007;51:601–5
   PubMedGoogle Scholar
• Rocha MP, Marcondes JA, Barcellos CR, et al. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecol Endocrinol 2011;27:814–9
   PubMed Web of Science ®Google Scholar